View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
Launch Excellence, the U.S. Edition: The Rewrite of the Business of Launch – Optimize
"Aligning legislative requirements, payer expectations regarding pricing and evidence, and meeting patients’ needs is now crucial for successful launches.
Learn moreExternal comparators (ECs) built from real world data (RWD), and the resulting real world evidence (RWE), are increasingly being applied to support initial regulatory approval and labeling changes for marketed products.
Join us for this webinar where we will discuss recommendations from the FDA draft guidance and success factors for getting ECs right in oncology.
Key Topics:
- Overview and implications of the recent FDA draft guidance on ECs
- Operational and key methodological success factors for developing ECs
- Additional clinical considerations within the indication of oncology
Speaker
Leanne Li, MPH, MBA
Sr. Principal, Real World Strategy and Innovation, U.S. Real World Solutions, IQVIA
Mayank Raizada, MS
Principal, Regulatory Science & Strategy, IQVIA
David Alsadius, MD, PhD
Sr. Medical Director, Medical Strategy Lead for Oncology, IQVIA
Mohsin Shah, MBBS, MSCE
Consultant Epidemiologist, Epidemiology and Drug Safety, U.S. Real World Solutions, IQVIA